1. Seelich T, Redl H: Theoretische Grundlagen des Fibrinklebers. In: Fibrinogen, Fibrin und Fibrinkleber, ed. Schimpf K FK Schattauer Verlag, Stuttgart — New York, p. 199–208, 1980
2. Alter HJ, Purcell RH, Holland PV, Alling DW, Koziol DE: Donor transaminase and recipient hepatitis. Impact on blood transfusion services. Jama, 246: 6, p. 630–634, 1981
3. Hornbrook MC, Dodd RY, Jacobs P, Friedman LI, Sherman KE: Reducing the incidence of non-A, non-B post-transfusion hepatitis by testing donor blood for alanine aminotransferase. N Engl. J Med, 307: 21, 1315–1321, 1982
4. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J: Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med, 304: 17, 989–1035, 1981
5. Empfehlungen der Deutschen Gesellschaft für Klinische Chemie. Z klin Chem u klin Biochem, 10, 182–192, 1972